🇺🇸 FDA
Pipeline program

Gemcitabine

16-1066

Unknown small_molecule active

Quick answer

Gemcitabine for Pancreatic Cancer is a Unknown program (small_molecule) at HALOZYME THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
HALOZYME THERAPEUTICS, INC.
Indication
Pancreatic Cancer
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials